T. Rowe Price Investment Management, Inc. Cytokinetics Inc Put Options Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding CYTK
# of Institutions
408Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$448 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$362 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$244 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$186 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.07MShares$93.9 Million4.32% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $2.88B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...